SABS · SAB Biotherapeutics, Inc. · Off Exchange
Market Cap
$310.26M
Shares
90.99M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-08-03 | 675,774 | 531,798 | 1,207,572 | 44.0% |
| 2026-07-27 | 218,955 | 542,867 | 761,822 | 41.5% |
| 2026-07-20 | 452,690 | 1,209,706 | 1,662,396 | 50.9% |
| 2026-07-13 | 440,313 | 546,898 | 987,211 | 46.6% |
| 2026-07-06 | 496,164 | 556,158 | 1,052,322 | 32.3% |
| 2026-06-29 | 316,713 | 274,912 | 591,625 | 37.2% |
| 2026-06-22 | 564,753 | 1,420,519 | 1,985,272 | 25.8% |
| 2026-06-15 | 1,452,447 | 4,957,041 | 6,409,488 | 55.6% |
| 2026-06-08 | 487,855 | 317,662 | 805,517 | 52.9% |
| 2026-06-01 | 351,055 | 612,932 | 963,987 | 48.5% |
| 2026-05-25 | 133,742 | 366,695 | 500,437 | 46.0% |
| 2026-05-18 | 380,296 | 653,926 | 1,034,222 | 41.0% |
| 2026-05-11 | 879,923 | 2,064,560 | 2,944,483 | 50.1% |
| 2026-05-04 | 2,455,276 | 3,388,157 | 5,843,433 | 52.9% |
| 2026-04-27 | 486,274 | 690,201 | 1,176,475 | 52.1% |
| 2026-04-20 | 428,260 | 532,227 | 960,487 | 45.0% |
| 2026-04-13 | 406,165 | 401,970 | 808,135 | 33.3% |
| 2026-04-06 | 182,359 | 185,538 | 367,897 | 34.3% |
| 2026-03-30 | 225,062 | 1,131,287 | 1,356,349 | 55.9% |
| 2026-03-23 | 788,127 | 330,920 | 1,119,047 | 32.9% |
| 2026-03-16 | 969,315 | 1,418,588 | 2,387,903 | 40.1% |
| 2026-03-09 | 2,291,042 | 3,138,205 | 5,429,247 | 69.8% |
| 2026-03-02 | 224,521 | 768,810 | 993,331 | 65.6% |
| 2026-02-23 | 333,460 | 859,899 | 1,193,359 | 68.8% |
| 2026-02-16 | 216,677 | 247,728 | 464,405 | 47.6% |
| 2026-02-09 | 237,116 | 437,501 | 674,617 | 47.5% |
| 2026-02-02 | 291,039 | 467,466 | 758,505 | 41.2% |
| 2026-01-26 | 321,431 | 1,020,626 | 1,342,057 | 57.8% |
| 2026-01-19 | 205,540 | 1,044,944 | 1,250,484 | 66.5% |
| 2026-01-12 | 544,192 | 1,453,162 | 1,997,354 | 69.9% |
| 2026-01-05 | 350,758 | 1,152,442 | 1,503,200 | 73.1% |
| 2025-12-29 | 74,669 | 210,745 | 285,414 | 56.8% |
| 2025-12-22 | 94,910 | 114,732 | 209,642 | 56.1% |
| 2025-12-15 | 220,954 | 482,103 | 703,057 | 22.7% |
| 2025-12-08 | 157,458 | 390,161 | 547,619 | 44.9% |
| 2025-12-01 | 291,633 | 427,531 | 719,164 | 48.2% |
| 2025-11-24 | 277,453 | 214,631 | 492,084 | 47.4% |
| 2025-11-17 | 132,713 | 362,241 | 494,954 | 46.5% |
| 2025-11-10 | 194,275 | 194,902 | 389,177 | 47.0% |
| 2025-11-03 | 217,340 | 279,726 | 497,066 | 46.8% |
| 2025-10-27 | 202,389 | 241,560 | 443,949 | 51.5% |
| 2025-10-20 | 676,144 | 602,419 | 1,278,563 | 57.6% |
| 2025-10-13 | 161,439 | 367,241 | 528,680 | 52.2% |
| 2025-10-06 | 288,676 | 1,277,894 | 1,566,570 | 61.0% |
| 2025-09-29 | 58,205 | 1,286,916 | 1,345,121 | 42.9% |
| 2025-09-22 | 102,375 | 339,152 | 441,527 | 46.8% |
| 2025-09-15 | 355,120 | 1,667,610 | 2,022,730 | 54.4% |
Showing 1–47 of 47 weeks
Key facts
CIK
1833214
CUSIP
78397T202
13F (30d)
55 filings
55 filers
Visit website
Investor relations